Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2102.00 | 2583.50 | 0.8136 | 0.6561 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2175.00 | 2583.50 | 0.8419 | 0.7087 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 1250.00 | 1210.88 | 2519.00 | 2583.50 | 0.9750 | 0.9543 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 2383.00 | 2583.50 | 0.9224 | 0.8575 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2700.00 | 2583.50 | 1.0451 | 1.0823 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2702.00 | 2583.50 | 1.0459 | 1.0837 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 3037.00 | 2583.50 | 1.1755 | 1.3189 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2870.00 | 2583.50 | 1.1109 | 1.2019 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2506.00 | 2583.50 | 0.9700 | 0.9451 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2633.00 | 2583.50 | 1.0192 | 1.0350 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 1250.00 | 1210.88 | 2686.00 | 2583.50 | 1.0397 | 1.0725 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2772.00 | 2583.50 | 1.0730 | 1.1331 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2666.00 | 2583.50 | 1.0319 | 1.0583 | |
| SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2456.00 | 2583.50 | 0.9507 | 0.9095 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2701.00 | 2583.50 | 1.0455 | 1.0830 | |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2359.00 | 2583.50 | 0.9131 | 0.8404 |
| SK-BR-3 | Etoposide | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2478.00 | 2583.50 | 0.9592 | 0.9252 |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 1250.00 | 1210.88 | 1487.00 | 2583.50 | 0.5756 | 0.2067 |
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 1250.00 | 1210.88 | 2738.00 | 2583.50 | 1.0598 | 1.1091 |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 1250.00 | 1210.88 | 1123.00 | 2583.50 | 0.4347 | -0.0666 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 1250.00 | 1210.88 | 2613.00 | 2583.50 | 1.0114 | 1.0209 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2614.00 | 2583.50 | 1.0118 | 1.0216 |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2538.00 | 2583.50 | 0.9824 | 0.9678 | |
| SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2351.00 | 2583.50 | 0.9100 | 0.8347 | |
| SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 3843.00 | 4479.50 | 0.8579 | 0.6833 |